Through MDM2 stabilization and p53 degradation, MTBP inhibits the expression of the p53 effectors of apoptosis and cell cycle arrest/cell senescence, upregulates the expression of c-myc oncoprotein, and promotes tumor growth and treatment resistance. The gene discussed is TP53; the disease is neoplasm.